We read with interest the recent study by Brunner et al, 1 which provides compelling evidence that high concentrations of nitric oxide (NO) generated from endothelial nitric oxide synthase (eNOS) overexpression reduces cardiac contraction by decreasing myocardial calcium sensitivity. Their data also suggest that NO has very little effect on the autonomic modulation of cardiac excitability. This latter finding, however, must be viewed with caution. Although there is no convincing functional evidence supporting a role for endogenously produced NO in the postsynaptic autonomic regulation of heart rate, NO donors are capable of increasing heart rate by cyclic guanosine monophosphate (cGMP) dependent activation of the hyperpolarization-activated current (I f ) in pacemaking cells. 2 Moreover, NO generated from neuronal nitric oxide synthase (nNOS) in intrinsic cardiac ganglia 3 during stimulation of the vagus nerve enhances the magnitude of the bradycardia 4 by facilitating acetylcholine release. 5 Consistent with this, nNOS knockout mice have an impaired heart rate response to vagal activation, whereas their rate response to acetylcholine itself remains intact. 3 Thus, although eNOS-NO has very little effect on the cholinergic regulation of heart rate to bath applied neurotransmitter, nNOS-NO activated physiologically by vagal stimulation clearly affects heart rate control. When these results are taken together with Brunner et al, 1 they further reinforce the notion of the differential sitespecific action that various NOS isoforms play in modulating cardiac function. 
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To the Editor:
We read with interest the recent study by Brunner et al, 1 which provides compelling evidence that high concentrations of nitric oxide (NO) generated from endothelial nitric oxide synthase (eNOS) overexpression reduces cardiac contraction by decreasing myocardial calcium sensitivity. Their data also suggest that NO has very little effect on the autonomic modulation of cardiac excitability. This latter finding, however, must be viewed with caution. Although there is no convincing functional evidence supporting a role for endogenously produced NO in the postsynaptic autonomic regulation of heart rate, NO donors are capable of increasing heart rate by cyclic guanosine monophosphate (cGMP) dependent activation of the hyperpolarization-activated current (I f ) in pacemaking cells. 2 Moreover, NO generated from neuronal nitric oxide synthase (nNOS) in intrinsic cardiac ganglia 3 during stimulation of the vagus nerve enhances the magnitude of the bradycardia 4 by facilitating acetylcholine release. 5 Consistent with this, nNOS knockout mice have an impaired heart rate response to vagal activation, whereas their rate response to acetylcholine itself remains intact. 3 Thus, although eNOS-NO has very little effect on the cholinergic regulation of heart rate to bath applied neurotransmitter, nNOS-NO activated physiologically by vagal stimulation clearly affects heart rate control. When these results are taken together with Brunner et al, 1 they further reinforce the notion of the differential sitespecific action that various NOS isoforms play in modulating cardiac function. 
Neil
Response
We thank Drs Herring and Paterson for their comments on our recent publication, 1 in which we found no effect of myocytederived nitric oxide (NO) on heart rate in conscious mice, or on beating rate in isolated hearts perfused with acetylcholine. The authors correctly point out recent evidence for a bradycardic role of NO derived from neuronal NO synthase (nNOS). We are aware of the significantly higher mean heart rate and lower heart rate variability in conscious nNOS knockout mice, 2 as well as the higher baseline heart rate in isolated right atrial preparations from such animals, 3 but would like to stress that the relevance of these observations for in vivo control of heart rate in genetically unaltered mice or other species is not known. Also, in the latter report, pharmacological inhibition of nNOS was only marginally effective in attenuating heart rate response to vagus nerve stimulation (difference to control, 15 to 20 beats per min, at a basal heart rate of ‫023ف‬ min Ϫ1 ), and the tachycardia induced by atropine was only marginally less in nNOS knockout atria than normal mouse atria (5.4% versus 8.0%), 3 casting doubt on the significance of prejunctional NO in the release of acetylcholine from parasympathetic nerve terminals in this preparation. Finally, although stimulation of the hyperpolarization-activated inward current (I f ) via NO/cGMP may explain the increased beating rate of isolated spontaneously beating guinea-pig right atria, 4 blockade of this current with Cs ϩ had a similar effect on spontaneous beating rate in wild-type and nNOS knockout mouse atria, 3 suggesting that I f did not likely contribute to the elevated heart rate in the nNOS knockout atria of this species. Thus, further studies are necessary to substantiate a role for nNOS-derived NO in control of heart rate in the baseline state.
